Clinical Trials on Mental Wellbeing in Japan

Total 1508 results

Mitsubishi Tanabe Pharma Corporation

Completed

A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term Trial of OPC-34712 in Patients With Schizophrenia

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

Autism

Japan
Otsuka Pharmaceutical Co., Ltd.

Terminated

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Agitation Associated With Dementia of the Alzheimer's Type

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial of OPC-64005 for Major Depressive Disorder

Major Depressive Disorder

Japan
Nagoya City University

Recruiting

The Remote Family Support Programs for Eating Disorders

Eating Disorders

Japan
National Center of Neurology and Psychiatry, Japan

Completed

Cognitive Rehabilitation During Transcranial Direct Current Stimulation

Neurocognitive Disorders | Transcranial Direct Current Stimulation

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of Brexpiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Tadashi Hasegawa

Completed

Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)

Bipolar Disorder

Japan
United States Naval Medical Center, San Diego

Completed

Acupuncture for Sleep Disturbances in Post-Deployment Military Service Members

Sleep Disturbance

Japan
Heptares Therapeutics Limited
Sosei

Withdrawn

A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB)

Dementia With Lewy Bodies

Japan
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia

Schizophrenia

Japan
Eli Lilly and Company

Completed

Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia

Schizophrenia

Japan
Gunma University

Completed

Treating Depressed Mood With a Smartphone-delivered Positive Word Stimulation for Subthreshold Depression

Subthreshold Depression

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

Schizophrenia

Japan
Kibi International University

Completed

Smartphone Intervention for Subthreshold Depression

Subthreshold Depression

Japan
Kurihama Medical and Addiction Center

Unknown

The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers (ETFDDG)

Pathological Gambling

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia

Schizophrenia

Japan
Yokohama City University

Completed

Shared Decision Making for Patients With First-admission Schizophrenia

Schizophrenia

Japan
Kyoto University
Nagoya City University

Completed

Telephone Cognitive-Behavioral Therapy (CBT) for Subthreshold Depression and Presenteeism in Workplace

Depression

Japan
Otsuka Pharmaceutical Co., Ltd.

Active, not recruiting

Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients With Alcohol Dependence

Alcohol Dependence

Japan
Otsuka Pharmaceutical Co., Ltd.
H. Lundbeck A/S

Completed

A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence

Alcohol Dependence

Japan
Otsuka Pharmaceutical Co., Ltd.

Active, not recruiting

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Bipolar Disorder I

Japan
Otsuka Pharmaceutical Co., Ltd.
H. Lundbeck A/S

Completed

A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects

Alcohol Dependence

Japan
Japan Society of Clinical Research

Completed

Evaluation of mediVR-KAGURA Guided Therapy

Cognitive Dysfunction | Physical Disability

Japan
Astellas Pharma Inc

Completed

Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Kyoto University, Graduate School of Medicine
Philips Healthcare; Philips Respironics

Completed

The Effect of Adaptive Servo Ventilation and Oxygen Therapy in Central Sleep Apnea Patients

Sleep Apnea | Chronic Heart Failure

Japan
Kibi International University

Completed

Study Protocol for a Smartphone Application-based Intervention for Subthreshold Depression

Subthreshold Depression

Japan
Okayama University

Completed

Association of Plasma Melatonin Levels With Delirium

Postoperative Delirium

Japan
GlaxoSmithKline

Completed

Long-term Study Of Paroxetine in Women and Men (SAD)

Social Phobia

Japan
Kyoto University, Graduate School of Medicine
Ministry of Health, Labour and Welfare, Japan

Completed

Patient Reported Outcomes in Living Donor Lung Transplantation

Lung Transplantation

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Early Phase 2 Clinical Study of TS-142 in Patients With Insomnia Disorder

Insomnia Disorder

Japan
Eli Lilly and Company

Completed

A Study of LY2624803 in Japanese Participants With Transient Insomnia

Sleep Initiation and Maintenance Disorders

Japan
National Center of Neurology and Psychiatry, Japan

Completed

Japan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP Study)

Anxiety Disorders | Depressive Disorders

Japan
Astellas Pharma Inc

Completed

Oral Multiple-dose Study in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Development & Commercialization, Inc.

Recruiting

Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia

Acute Schizophrenia

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Late Phase II Study of TS-142 in Patients With Insomnia

Patients With Insomnia

Japan
Osaka City University

Completed

Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder (OCDDRUG)

SSRI-Refractory Obsessive-Compulsive Disorder

Japan
Hamamatsu University
Japan Agency for Medical Research and Development

Unknown

A Trial of TTA-121 on Autism Spectrum Disorder

Autism Spectrum Disorder

Japan
University of Shizuoka

Completed

Effects of Green Tea Consumption on Homocysteine Metabolism and Cognitive Dysfunction

Cognitive Impairment

Japan
Komazawa University

Completed

A Pilot Study of Loving-Kindness Meditation for Social Anxiety Disorder

Compassion | Social Anxiety Disorder

Japan
National Cerebral and Cardiovascular Center

Completed

A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)

Mild Cognitive Impairment

Japan
Otsuka Pharmaceutical Co., Ltd.
H. Lundbeck A/S

Completed

A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)

Alcohol Dependence

Japan
Showa University

Completed

Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder (AFADTRMDD)

Major Depressive Disorder

Japan
Bayer

Completed

LEVITRA® 20mg Special Drug Use Investigation (Long-term)

Erectile Dysfunction

Japan
Janssen Pharmaceutical K.K.

Completed

A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants

Healthy

Japan
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

Impotence

Japan
Ashikaga Red Cross Hospital

Completed

Response of Psychiatric Outpatients to the Great East Japan Earthquake

Mood Disorders

Japan

3

Subscribe